Bank of Montreal’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $996K | Buy |
11,455
+1,788
| +18% | +$108K | ﹤0.01% | 2088 |
|
|
2026
Q1 | $390K | Buy |
9,667
+1,004
| +12% | +$37.5K | ﹤0.01% | 2512 |
|
|
2025
Q4 | $301K | Sell |
8,663
-425
| -5% | -$33.4K | ﹤0.01% | 2587 |
|
|
2025
Q3 | $755K | Sell |
9,088
-8,263
| -48% | -$598K | ﹤0.01% | 2086 |
|
|
2025
Q2 | $1.27M | Buy |
17,351
+353
| +2% | +$25.6K | ﹤0.01% | 1787 |
|
|
2025
Q1 | $1.94M | Buy |
16,998
+3,320
| +24% | +$202K | ﹤0.01% | 1528 |
|
|
2024
Q4 | $689K | Buy |
13,678
+1,122
| +9% | +$58.8K | ﹤0.01% | 2052 |
|
|
2024
Q3 | $552K | Buy |
12,556
+400
| +3% | +$14.2K | ﹤0.01% | 2348 |
|
|
2024
Q2 | $395K | Buy |
12,156
+580
| +5% | +$15.9K | ﹤0.01% | 2558 |
|
|
2024
Q1 | $294K | Sell |
11,576
-80
| -0.7% | -$1.89K | ﹤0.01% | 2791 |
|
|
2023
Q4 | $385K | Buy |
11,656
+773
| +7% | +$21.2K | ﹤0.01% | 2697 |
|
|
2023
Q3 | $368K | Sell |
10,883
-21,242
| -66% | -$615K | ﹤0.01% | 2660 |
|
|
2023
Q2 | $749K | Buy |
32,125
+17,388
| +118% | +$400K | ﹤0.01% | 2338 |
|
|
2023
Q1 | $322K | Sell |
14,737
-167,130
| -92% | -$3.66M | ﹤0.01% | 2738 |
|
|
2022
Q4 | $3.82M | Sell |
181,867
-29,159
| -14% | -$731K | ﹤0.01% | 1438 |
|
|
2022
Q3 | $5.84M | Buy |
211,026
+3,603
| +2% | +$96.4K | ﹤0.01% | 1267 |
|
|
2022
Q2 | $5.26M | Buy |
207,423
+180,918
| +683% | +$3.94M | ﹤0.01% | 1404 |
|
|
2022
Q1 | $643K | Sell |
26,505
-1,398
| -5% | -$29.7K | ﹤0.01% | 2657 |
|
|
2021
Q4 | $544K | Sell |
27,903
-8,118
| -23% | -$165K | ﹤0.01% | 2328 |
|
|
2021
Q3 | $731K | Sell |
36,021
-1,925
| -5% | -$40.3K | ﹤0.01% | 2665 |
|
|
2021
Q2 | $846K | Buy |
37,946
+7,110
| +23% | +$158K | ﹤0.01% | 2588 |
|
|
2021
Q1 | $707K | Sell |
30,836
-17,901
| -37% | -$478K | ﹤0.01% | 2436 |
|
|
2020
Q4 | $1.32M | Buy |
48,737
+39,739
| +442% | +$837K | ﹤0.01% | 2060 |
|
|
2020
Q3 | $159K | Sell |
8,998
-3,197
| -26% | -$50.9K | ﹤0.01% | 2836 |
|
|
2020
Q2 | $204K | Buy |
12,195
+8,179
| +204% | +$115K | ﹤0.01% | 2724 |
|
|
2020
Q1 | $48K | Sell |
4,016
-12,612
| -76% | -$156K | ﹤0.01% | 2907 |
|
|
2019
Q4 | $202K | Buy |
16,628
+1,969
| +13% | +$27.4K | ﹤0.01% | 3159 |
|
|
2019
Q3 | $207K | Buy |
14,659
+458
| +3% | +$5.63K | ﹤0.01% | 2881 |
|
|
2019
Q2 | $158K | Buy |
14,201
+10,674
| +303% | +$119K | ﹤0.01% | 3055 |
|
|
2019
Q1 | $41K | Sell |
3,527
-1,304
| -27% | -$16.2K | ﹤0.01% | 3411 |
|
|
2018
Q4 | $64K | Buy |
4,831
+1,202
| +33% | +$15.9K | ﹤0.01% | 3176 |
|
|
2018
Q3 | $51K | Sell |
3,629
-9,173
| -72% | -$128K | ﹤0.01% | 3383 |
|
|
2018
Q2 | $201K | Sell |
12,802
-3,163
| -20% | -$55K | ﹤0.01% | 2755 |
|
|
2018
Q1 | $263K | Sell |
15,965
-62,345
| -80% | -$1.16M | ﹤0.01% | 2500 |
|
|
2017
Q4 | $1.42M | Buy |
78,310
+51,149
| +188% | +$926K | ﹤0.01% | 1778 |
|
|
2017
Q3 | $524K | Sell |
27,161
-7,770
| -22% | -$116K | ﹤0.01% | 2250 |
|
|
2017
Q2 | $413K | Buy |
34,931
+18,389
| +111% | +$200K | ﹤0.01% | 2351 |
|
|
2017
Q1 | $182K | Hold |
16,542
| – | – | ﹤0.01% | 2521 |
|
|
2016
Q4 | $138K | Buy |
16,542
+3,288
| +25% | +$25.8K | ﹤0.01% | 2679 |
|
|
2016
Q3 | $86K | Sell |
13,254
-5,170
| -28% | -$30.1K | ﹤0.01% | 2855 |
|
|
2016
Q2 | $100K | Sell |
18,424
-5,379
| -23% | -$28K | ﹤0.01% | 2797 |
|
|
2016
Q1 | $111K | Hold |
23,803
| – | – | ﹤0.01% | 2754 |
|
|
2015
Q4 | $119K | Buy |
+23,803
| New | +$107K | ﹤0.01% | 2693 |
|
|
2014
Q3 | – | Sell |
-1,330
| Closed | -$4K | – | 4067 |
|
|
2014
Q2 | $4K | Buy |
+1,330
| New | +$3.92K | ﹤0.01% | 4240 |
|
Other funds holding CORT
ISL
PA
Bank of Montreal's CORT Position: Q2 2026 in Review
Bank of Montreal increased its Corcept Therapeutics (CORT) stake by 18% in Q2 2026, buying an estimated $108K and bringing the position to 11,455 shares worth $996K. The position accounts for ﹤0.01% of the portfolio, ranked #2088.
Bank of Montreal first reported a position in CORT in Q2 2014 and has held it in 44 quarters since. The position peaked at $5.84M in Q3 2022. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- Bank of Montreal held 11,455 shares of Corcept Therapeutics worth $996K as of Q2 2026.
- Bank of Montreal bought 1,788 Corcept Therapeutics shares in Q2 2026, an estimated $108K.
- Corcept Therapeutics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2088 holding.
- Bank of Montreal first reported a position in Corcept Therapeutics in Q2 2014 and has held it in 44 quarters since.
- Bank of Montreal's Corcept Therapeutics position peaked at $5.84M in Q3 2022.
- 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.